← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHANDONG · Approved 2026-01-15
Drug application
- FDA Application #
ANDA219765- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- OXALIPLATIN
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SHANDONG
- Manufacturer
- Shandong New Time Pharmaceutical Co., Ltd.
- First approval
- 2026-01-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown